Prognostic utility of tumor-infiltrating lymphocytes in residual tumor after neoadjuvant chemotherapy with trastuzumab for HER2-positive breast cancer

JOURNAL ARTICLE published 7 February 2019 in Scientific Reports

Authors: Sasagu Kurozumi | Kenichi Inoue | Hiroshi Matsumoto | Takaaki Fujii | Jun Horiguchi | Tetsunari Oyama | Masafumi Kurosumi | Ken Shirabe